My best co-registration cases

Prof Andrew Sharp qualified from Edinburgh Medical School in 1998 and is Professor of Cardiology at the University Hospital of Wales and Cardiff University in the U.K. He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training. He completed the prestigious Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus Hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo. He also spent three years training in interventional cardiology at Imperial College Hospitals in London. Prof Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his research interests include intracoronary imaging and physiology. as well as the use of device-based treatments for hypertension and pulmonary embolism.

Professor Jacek Legutko is an interventional cardiologist with over 25 years of experience in the field. His main research interest is focused on primary PCI in acute myocardial infarction, intravascular imaging and physiology lesion assessment in the cathlab, as well as complex percutaneous coronary interventions (PCI). He has performed a series of studies in those areas and has participated in many clinical trials. Professor Legutko is a Course Director at the New Frontiers in Interventional Cardiology (NFIC), an international congress organized annually in Krakow, Poland since 1999. He has also served as a Faculty member, live case operator and facilitator for several interventional cardiology meetings including EuroPCR, PCR Africa, TCT, C3, CardioEgypt, and WCCI. Professor Legutko received several professional awards, including prestigious “Andreas Award” granted for his personal impute on the development of interventional cardiology in Poland.

Dr Justin Davies is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and an interventional cardiologist with over 15 years of experience as a leading educator in the field. His clinical and academic career was established at Hammersmith Hospital, Imperial College London, where he built an international reputation for innovation in cardiovascular medicine. Over the course of his career, he has successfully mentored 15 PhD students, published more than 500 peer-reviewed papers — including landmark studies in the New England Journal of Medicine and The Lancet — and holds 20 patents in cardiovascular medicine and technology. He was the co-principal investigator of the DEFINE-FLAIR study, which helped establish iFR (Instantaneous Wave-Free Ratio), a diagnostic technique he invented, as a globally adopted standard in coronary physiology. His work reflects a unique blend of scientific innovation, academic leadership, and clinical excellence. In addition to his research and academic commitments, Justin is CEO of Cerebria AI, where he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools. Under his leadership, Cerebria AI is advancing cutting-edge solutions that integrate artificial intelligence with frontline cardiology to enhance clinical decision-making and patient outcomes. Combining deep clinical expertise with entrepreneurial vision, he continues to guide international ventures through funding, regulatory pathways, and commercialization, while remaining committed to transforming cardiovascular care on a global scale.

A consultant/attending. Features in 94 videos on Wondr Medical. SAYAN SEN generally speaks on Fractional Flow Reserve (FFR), Live Cases, Instantaneous wave-Free Ratio (iFR), Renal Denervation (RDN), and Catheter laboratory skills.